date,title,source
Oct-23-18,"Vaccinex, Inc. to Participate on a Panel and Meet with Investors at the BTIG Healthcare Conference October 25, 2018",GlobeNewswire
Nov-06-18,"Vaccinex, Inc. to Present Data on Its Semaphorin 4D Monoclonal Antibody Programs at Two Conferences Focused on Cancer Immunotherapy and Huntingtons Disease",GlobeNewswire
Nov-12-18,"Vaccinex, Inc. Presents Overview of the Clinical Development of VX15 (pepinemab) for the Potential Treatment of Huntingtons Disease at the Huntington Study Groups 2018 Annual Meeting",GlobeNewswire
Nov-13-18,Vaccinex Reports Third Quarter 2018 Financial Results and Provides Corporate Update,GlobeNewswire
